Download PDF
Semin Respir Crit Care Med 2004; 25(2): 203-219
DOI: 10.1055/s-2004-824904
Copyright © 2004 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA.

Noninvasive Aspergillus Pulmonary Disease

Marc A. Judson1
  • 1Division of Pulmonary and Critical Care Medicine, Medical University of South Carolina, Charleston, South Carolina
Further Information

Publication History

Publication Date:
19 April 2004 (online)

    Permissions and Reprints

Noninvasive Aspergillus pulmonary disease may be the result of a host response to Aspergillus antigens or colonization of the lung with Aspergillus species. The prototype example of each of these phenomena are allergic bronchopulmonary aspergillosis and aspergilloma. Allergic bronchopulmonary aspergillosis is a form of asthma associated with a Type I, III, and IV allergic response to Aspergillus antigens. It presents clinically as asthma but is also associated with bronchiectasis, airway destruction, and permanent lung injury if inadequately treated. Treatment consists of anti-inflammatory agents such as corticosteroids. Antifungal agents may also be useful to lower the fungal antigen load. Aspergillomas grow in areas of devitalized lung. They may manifest as asymptomatic radiographic abnormalities. The concern is that they may lead to hemoptysis that can be life threatening. Definitive treatment is surgical resection, but this is often prohibited because these patients often have inadequate lung function to tolerate thoracic surgery. Other treatment options include azoles and percutaneous instillation of antifungals.

KEYWORDS

Aspergillus - aspergilloma - allergic bronchopulmonary aspergillosis - therapy - azoles - corticosteroids

REFERENCES

  • 1 Stevens D A, Kan V L, Judson M A et al.. Practice guidelines for disease caused by Aspergillus .  Clin Infect Dis. 2000;  30 696-709
    CrossrefPubMedGoogle Scholar
  • 2 Gerson S L, Talbot G H, Hurwitz S et al.. Prolonged granulocytopenia: the major risk factor fsor invasive pulmonary aspergillosis in patients with acute leukemia.  Ann Intern Med. 1984;  100 345-351
    PubMedGoogle Scholar
  • 3 Wald A, Leisenring W, van Burik J A et al.. Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation.  J Infect Dis. 1997;  175 1459-1466
    CrossrefPubMedGoogle Scholar
  • 4 Hibberd P L, Rubin R H. Clinical aspects of fungal infection in organ transplant recipients.  Clin Infect Dis. 1994;  19(suppl 1) S33-S40
    PubMedGoogle Scholar
  • 5 Denning D W, Follansbee S E, Scolaro M et al.. Pulmonary aspergillosis in the acquired immunodeficiency syndrome.  N Engl J Med. 1991;  324 654-662
    CrossrefPubMedGoogle Scholar
  • 6 Stevens D A, Schwartz H J, Lee J Y et al.. A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis.  N Engl J Med. 2000;  342 756-762
    CrossrefPubMedGoogle Scholar
  • 7 Shah A, Khan Z U, Charturvedi S et al.. Allergic bronchopulmonary aspergillosis with coexistent aspergilloma: a long-term follow-up.  J Asthma. 1989;  26 109-115
    PubMedGoogle Scholar
  • 8 Judson M A. Allergic bronchopulmonary aspergillosis.  Pulmonary Critical Care Update. 2003;  17 lesson 17
    PubMedGoogle Scholar
  • 9 Vlahakis N E, Aksamit T R. Diagnosis and treatment of allergic bronchopulmonary aspergillosis.  Mayo Clin Proc. 2001;  76 930-938
    PubMedGoogle Scholar
  • 10 Schuyler M R. Allergic bronchopulmonary aspergillosis.  Clin Chest Med. 1983;  4 15-22
    PubMedGoogle Scholar
  • 11 Patterson R, Greenberger P A, Harris K E. Allergic bronchopulmonary aspergillosis [editorial].  Chest. 2000;  118 7-8
    CrossrefPubMedGoogle Scholar
  • 12 Hinson K F, Moon A J, Plummer N S. Bronchopulmonary aspergillosis.  Thorax. 1952;  7 317-333
    CrossrefPubMedGoogle Scholar
  • 13 Greenberger P. Allergic bronchopulmonary aspergillosis.  Clin Allergy Immunol. 2002;  16 449-468
    PubMedGoogle Scholar
  • 14 Ricketti A J, Greenberger P A, Patterson R. Immediate-type reactions in patients with allergic bronchopulmonary aspergillosis.  J Allergy Clin Immunol. 1983;  71 541-545
    PubMedGoogle Scholar
  • 15 Malo J L, Hawkins R, Pepys J. Studies in chronic allergic bronchopulmonary aspergillosis: clinical and physiological findings.  Thorax. 1977;  32 254-261
    PubMedGoogle Scholar
  • 16 Varkey B. Allergic bronchopulmonary aspergillosis: clinical perspectives.  Immunol Allergy Clin North Am. 1998;  18 480-501
    PubMedGoogle Scholar
  • 17 Graves T S, Fink J N, Patterson R, Kurup V P, Scanlon G T. A familial occurrence of allergic bronchopulmonary aspergillosis.  Ann Intern Med. 1979;  91 378-382
    PubMedGoogle Scholar
  • 18 Halwig M J, Kurup V P, Greenberger P A, Patterson R. A familial occurrence of allergic bronchopulmonary aspergillosis: a probable environmental source.  J Allergy Clin Immunol. 1985;  76 55-59
    PubMedGoogle Scholar
  • 19 Eaton T, Garrett J, Milne D, Frankel A, Wells A U. Allergic bronchopulmonary aspergillosis in an asthma clinic.  Chest. 2000;  118 66-72
    CrossrefPubMedGoogle Scholar
  • 20 Patterson R, Greenberger P A, Halwig J M, Liotta J L, Roberts M. Allergic bronchopulmonary aspergillosis: natural history and classification of early disease by serologic and roentegographic studies.  Arch Intern Med. 1986;  146 916-918
    CrossrefPubMedGoogle Scholar
  • 21 Basich J E, Graves T S, Nasir Baz M et al.. Allergic bronchopulmonary aspergillosis in corticosteroid-dependent asthmatics.  J Allergy Clin Immunol. 1981;  68 98-102
    PubMedGoogle Scholar
  • 22 Mrouch S, Spock A. Allergic bronchopulmonary aspergillosis in patients with cystic fibrosis.  Chest. 1994;  105 32-36
    PubMedGoogle Scholar
  • 23 Neppmuceno I B, Esrig S, Moss R B. Allergic bronchopulmonary aspergillosis in cystic fibrosis.  Chest. 1999;  115 364-370
    CrossrefPubMedGoogle Scholar
  • 24 McCarthy D S, Simon G, Hargreave F E. The radiological appearances in allergic bronchopulmonary aspergillosis.  Clin Radiol. 1970;  21 366-375
    CrossrefPubMedGoogle Scholar
  • 25 Neeld D A, Goodman L R, Gurney J W et al.. Computerized tomography in the evaluation of allergic bronchopulmonary aspergillosis.  Am Rev Respir Dis. 1990;  142 1200-1205
    CrossrefPubMedGoogle Scholar
  • 26 Lynch D A. Imagine of asthma and allergic bronchopulmonary mycosis.  Radiol Clin North Am. 1998;  36 129-142
    CrossrefPubMedGoogle Scholar
  • 27 Malo J P, Pepys J, Simon G. Studies in chronic allergic bronchopulmonary aspergillosis, II: Radiological findings.  Thorax. 1977;  32 262-268
    PubMedGoogle Scholar
  • 28 Phelan M S, Kerr I H. Allergic bronchopulmonary aspergillosis: the radiological appearance during long-term follow-up.  Clin Radiol. 1984;  35 385-392
    CrossrefPubMedGoogle Scholar
  • 29 Ward S, Heyneman L, Lee M J et al.. Accuracy of CT in the diagnosis of allergic bronchopulmonary aspergillosis in asthmatic patients.  AJR Am J Roentgenol. 1999;  173 937-942
    CrossrefPubMedGoogle Scholar
  • 30 Mitchell T AM, Hamilos D L, Lynch D A, Newell J D. Distribution and severity of bronchiectasis in allergic bronchopulmonary aspergillosis.  J Asthma. 2000;  37 65-72
    CrossrefPubMedGoogle Scholar
  • 31 Crameri R, Hemmann S, Ismail C, Menz G, Blaser K. Disease-specific recombinant allergens for the diagnosis of allergic bronchopulmonary aspergillosis.  Int'l Immunol. 1998;  10 1211-1216
    CrossrefPubMedGoogle Scholar
  • 32 Banerjee B, Kurup V P, Greenberger P A, Johnson B D, Fink J N. Cloning and expression of Aspergillus fumigatus allergen Asp f 16 mediating both humoral and cell-mediated immunity in allergic bronchopulmonary asgergillosis (ABPA).  Clin Exp Allergy. 2001;  31 761-770
    CrossrefPubMedGoogle Scholar
  • 33 Madan T, Banerjee B, Bhatnagar P K, Shah A, Sarma P U. Identification of 45kD antigen in immune complexes of patients of allergic bronchopulmonary aspergillosis.  Mol Cell Biochem. 1997;  166 111-116
    CrossrefPubMedGoogle Scholar
  • 34 Crameri R. Molecular cloning of Aspergillus fumigatus allergens and their role in allergic bronchopulmonary aspergillosis.  Chem Immunol. 2002;  81 73-93
    PubMedGoogle Scholar
  • 35 Kurup V P, Grunig G, Knutsen A P, Murali P S. Cytokines in allergic bronchopulmonary aspergillosis.  Res Immunol. 1998;  149 466-477
    PubMedGoogle Scholar
  • 36 Kahn S, McClellan J S, Knutsen A P. Increased sensitivity to IL-4 in patients with allergic bronchopulmonary aspergillosis.  Int'l Arch Allergy Immunol. 2000;  123 319-326
    PubMedGoogle Scholar
  • 37 Chauhan B, Santiago L, Hutcheson P S et al.. Evidence for the involvement of two different MHC class II regions in susceptibility or protection in allergic bronchopulmonary aspergillosis.  J Allergy Clin Immunol. 2000;  106 723-729
    CrossrefPubMedGoogle Scholar
  • 38 Cockrill B A, Hales C A. Allergic bronchopulmonary aspergillosis.  Annu Rev Med. 1999;  50 303-316
    CrossrefPubMedGoogle Scholar
  • 39 Ricketti A J, Greenberger P A, Mintzer R A, Patterson R. Allergic bronchopulmonary aspergillosis.  Arch Intern Med. 1983;  143 1553-1557
    CrossrefPubMedGoogle Scholar
  • 40 Elliott M W, Taylor J N. Allergic bronchopulmonary aspergillosis.  Clin Exp Allergy. 1997;  27(suppl 1) 55-59
    PubMedGoogle Scholar
  • 41 Greenberger P A, Patterson R. Allergic bronchopulmonary aspergillosis: model of bronchopulmonary disease with defined serologic, radiologic, pathologic and clinical findings from asthma to fatal destructive lung disease.  Chest. 1987;  91(suppl) 165S-171S
    PubMedGoogle Scholar
  • 42 Rosenberg M, Patterson R, Roberts M, Wang J. The assessment of immunologic and clinical changes occurring during corticosteroid therapy for allergic bronchopulmonary aspergillosis.  Am J Med. 1978;  64 599-606
    CrossrefPubMedGoogle Scholar
  • 43 Greenberger P A, Patterson R. Diagnosis and management of allergic bronchopulmonary aspergillosis.  Ann Allergy. 1986;  56 444-448
    PubMedGoogle Scholar
  • 44 Sahn S A, Lakshminarayan S. Allergic bronchopulmonary penicillosis.  Chest. 1973;  63 286-288
    CrossrefPubMedGoogle Scholar
  • 45 Hoshino H, Tagaki S, Kon H et al.. Allergic bronchopulmonary aspergillosis due to Aspergillus niger without bronchial asthma.  Respiration. 1999;  66 369-372
    CrossrefPubMedGoogle Scholar
  • 46 Rajkumar D C. Evaluation of allergic bronchopulmonary aspergillosis in patients with and without central bronchiectasis.  J Asthma. 2002;  39 473-477
    CrossrefPubMedGoogle Scholar
  • 47 Shah A, Panjabi C. Allergic bronchopulmonary aspergillosis: a review of a disease with a worldwide distribution.  J Asthma. 2002;  39 273-289
    CrossrefPubMedGoogle Scholar
  • 48 Wark P AB, Gibson P G. Allergic bronchopulmonary aspergillosis: new concepts of pathogenesis and treatment.  Respirology. 2001;  6 1-7
    CrossrefPubMedGoogle Scholar
  • 49 Capewell S, Chapman B J, Alexander F, Greening A P, Crompton G K. Corticosteroid treatment and prognosis in pulmonary eosinophilia.  Thorax. 1989;  44 925-929
    CrossrefPubMedGoogle Scholar
  • 50 Safirstein B H, D'Sousa M F, Simon G, Tai E HC, Pepys J. Five-year follow-up of allergic bronchopulmonary aspergillosis.  Am Rev Respir Dis. 1973;  108 450-459
    PubMedGoogle Scholar
  • 51 Middleton W G, Paterson I C, Grant I WB, Douglas A C. Asthmatic pulmonary eosinophilia: a review of 65 cases.  Br J Dis Chest. 1977;  71 115-122
    CrossrefPubMedGoogle Scholar
  • 52 Wang J L, Patterson R, Roberts M, Ghory A C. The management of allergic bronchopulmonary aspergillosis.  Am Rev Respir Dis. 1979;  120 87-92
    PubMedGoogle Scholar
  • 53 Fink J N. Allergic bronchopulmonary aspergillosis.  Chest. 1985;  87(suppl) 81S-84S
    PubMedGoogle Scholar
  • 54 Rosenberg M, Patterson R, Mintzer R, Cooper B J, Roberts M, Harris K E. Clinical and immunologic criteria for the diagnosis of allergic bronchopulmonary aspergillosis.  Ann Intern Med. 1977;  86 405-414
    PubMedGoogle Scholar
  • 55 McCarthy D S, Pepys J. Allergic bronchopulmonary aspergillosis: clinical immunology, II: Skin, nasal and bronchial tests.  Clin Allergy. 1971;  1 415-432
    PubMedGoogle Scholar
  • 56 Report to the Research Committee of the British Thoracic Society . Inhaled beclomethasone dipropionate in allergic bronchopulmonary aspergillosis.  Br J Dis Chest. 1979;  73 349-356
    CrossrefPubMedGoogle Scholar
  • 57 Hilton A M, Chatterjee S S. Bronchopulmonary aspergillosis: treatment with beclomethasone dipropionate.  Postgrad Med J. 1975;  51(suppl 4) 98-103
    PubMedGoogle Scholar
  • 58 Seaton A, Seaton R A, Wightman A JA. Management of allergic bronchopulmonary aspergillosis.  Q J Med. 1994;  87 529-537
    PubMedGoogle Scholar
  • 59 Leon E E, Craig T J. Antifungals in the treatment of allergic bronchopulmonary aspergillosis.  Ann Allergy Asthma Immunol. 1999;  82 511-517
    PubMedGoogle Scholar
  • 60 Germand P, Tuchais E. Allergic bronchopulmonary aspergillosis treated with itraconazole.  Chest. 1995;  107 883
    PubMedGoogle Scholar
  • 61 Pacheco A, Martin J A, Cuevas M. Serologic response to itraconazole in allergic bronchopulmonary aspergillosis.  Chest. 1993;  103 980-981
    PubMedGoogle Scholar
  • 62 De Beule K, De Doncher P, Cauwenbergh G et al.. The treatment of aspergillosis and aspergilloma with itraconazole, clinical results and open label study (1982-1987).  Mycoses. 1988;  31 476-485
    PubMedGoogle Scholar
  • 63 Chabasse D, Tuchais E, Bouchara J P, De Gentile L, Tuchais N. Efficacite de l'itraconazole dans le traitment de l'aspergillosis broncho-pulmonare allergique (ABPA), a propos de 2 observations.  Bull Soc Fr Myc Med. 1990;  19 271-275
    PubMedGoogle Scholar
  • 64 Nikaido Y, Nagata N, Yamamoto T, Yoshii C, Ohmori H, Kido N. A case of allergic bronchopulmonary aspergilosis successfully treated with itraconazole.  Respir Med. 1998;  92 118-119
    PubMedGoogle Scholar
  • 65 Matsuzaki Y, Jimi T, Tao Y, Takada S, Miyazaki N. Allergic bronchopulmonary aspergillosis successfully treated with itraconazole (Japanese).  Nihon Kyobu Shikkan Gakkai Zasshi. 1997;  35 352-356
    PubMedGoogle Scholar
  • 66 Salez F, Brichet A, Desurmont S, Grosbois J-M, Wallert B, Tuonnel A-B. Effects of itraconazole therapy in allergic bronchopulmonary aspergillosis.  Chest. 1999;  116 1665-1668
    CrossrefPubMedGoogle Scholar
  • 67 Mannes G P, van der Heide S, van Aalderen W M, Gerritsen J. Itraconazole and allergic bronchopulmonary aspergillosis in two brothers with cystic fibrosis.  Lancet. 1993;  341 492
    CrossrefPubMedGoogle Scholar
  • 68 Lebeau B, Pelloux H, Pinel C et al.. Itraconazole in the treatment of aspergillosis: a study of 16 cases.  Mycoses. 1994;  37 171-179
    PubMedGoogle Scholar
  • 69 Denning D W, Van Wye J E, Lewiston N J, Stevens D A. Adjunctive therapy of allergic bronchopulmonary aspergillosis with itraconazole.  Chest. 1991;  100 813-819
    CrossrefPubMedGoogle Scholar
  • 70 Measaki S, Iwakawa J, Higashiyama Y et al.. Antifungal activity of a new triazole, voriconazole (UK-109496), against clinical isolates of Aspergillus spp.  J Infect Chemother. 2000;  6 101-103
    PubMedGoogle Scholar
  • 71 Pfaller M A, Messer S A, Hollis R J, Jones R N. Sentry Participants Group. Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: report from SENTRY antimicrobial surveillance program, 2000.  Antimicrob Agents Chemother. 2002;  46 1032-1037
    CrossrefPubMedGoogle Scholar
  • 72 National Asthma Education and Prevention Program .Expert panel report, 2: Guidelines for the diagnosis and management of asthma; clinical practice guidelines, component 3. Bethesda, MD; National Institutes of Health 1997 Publication no. 97-405
    Google Scholar
  • 73 Radin R C, Greenberger P A, Patterson R, Ghory A. Mould counts and exacerbations of allergic bronchopulmonary aspergillosis.  Clin Allergy. 1983;  13 271-275
    PubMedGoogle Scholar
  • 74 Hanley-Lopez J, Clement L T. Allergic bronchopulmonary aspergillosis in cystic fibrosis.  Curr Opin Pulm Med. 2000;  6 540-544
    PubMedGoogle Scholar
  • 75 Mastella G, Rainisio M, Harms H K et al.. Epidemiologic Registry of Cystic Fibrosis: allergic bronchopulmonary aspergillosis in cystic fibrosis: a European epidemiological study.  Eur Respir J. 2000;  16 464-471
    CrossrefPubMedGoogle Scholar
  • 76 Geller D E, Kaplowitz H, Light M, Colin A A. Epidemiologic Study of Cystic Fibrosis: allergic bronchopulmonary aspergillosis in cystic fibrosis: reported prevalence, regional distribution, and patient characteristics.  Chest. 1999;  116 639-646
    CrossrefPubMedGoogle Scholar
  • 77 Hutcheson P S, Rejent A J, Slavin R G. Variability in parameters of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis.  J Allergy Clin Immunol. 1991;  88 390-394
    PubMedGoogle Scholar
  • 78 Moss R B. Allergic bronchopulmonary aspergillosis.  Clin Rev Allergy Immunol. 2002;  23 87-104
    PubMedGoogle Scholar
  • 79 Skov M, Hoiby N, Koch C. Itraconazole treatment of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis.  Allergy. 2002;  57 723-728
    CrossrefPubMedGoogle Scholar
  • 80 Miller P W, Hamosh A, Macek M et al.. Cystic fibrosis transmembrane conductance regulator (CFTR) mutations in allergic bronchopulmonary aspergillosis.  Am J Hum Genet. 1996;  59 45-51
    PubMedGoogle Scholar
  • 81 Marchand E, Verellen-Dumoulin C, Maresse M et al.. Frequency of cystic fibrosis transmembrane conductance regulator gene mutations and 5T allele in patients with allergic bronchopulmonary aspergillosis.  Chest. 2001;  119 762-767
    CrossrefPubMedGoogle Scholar
  • 82 Eaton T E, Weiner Miller P, Garrett J E, Cutting G R. Cystic fibrosis transmembrane conductance regulator gene mutations: do they play a role in the etiology of allergic bronchopulmonary aspergillosis?.  Clin Exp Allergy. 2002;  32 756-761
    CrossrefPubMedGoogle Scholar
  • 83 Fraser R, Pare J, Pare P et al.. Diagnosis of diseases of the chest. 3rd ed. Philadelphia; WB Saunders 1998
    Google Scholar
  • 84 British Tuberculosis and Thoracic Association . Aspergilloma and residual tuberculosis cavities: the result of a resurvey.  Tubercle. 1970;  51 227-245
    CrossrefPubMedGoogle Scholar
  • 85 Libshitz H I, Atkinson G W, Israel H L. Pleural thickening as a manifestation of Aspergillus superinfection.  AJR Am J Roentgenol. 1974;  120 883-886
    PubMedGoogle Scholar
  • 86 Glimp R A, Bayer A S. Pulmonary aspergilloma: diagnostic and therapeutic considerations.  Arch Intern Med. 1983;  143 303-308
    CrossrefPubMedGoogle Scholar
  • 87 Rafferty P, Biggs B, Crompton G K et al.. What happens to patients with pulmonary aspergilloma?.  Thorax. 1983;  38 579-583
    CrossrefPubMedGoogle Scholar
  • 88 Andrews C P, Weiner M H. Aspergillus antigen detection in bronchoalveolar lavage fluid from patients with invasive aspergillosis and aspergilloma.  Am J Med. 1982;  73 372-380
    CrossrefPubMedGoogle Scholar
  • 89 Smith R L, Morelli M J, Aranda C P. Pulmonary aspergilloma diagnosed by fiberoptic bronchoscopy.  Chest. 1987;  92 948-949
    CrossrefPubMedGoogle Scholar
  • 90 Severo L C, Londero A T, Picon P D, Rizzon C F, Tarasconi J C. Petriellidium boydii fungus ball in a patient with active tuberculosis.  Mycopathologia. 1982;  77 15-17
    PubMedGoogle Scholar
  • 91 Goldberg B. Radiological appearances in pulmonary aspergillosis.  Clin Radiol. 1962;  13 106-114
    CrossrefPubMedGoogle Scholar
  • 92 Irwin A. Radiology of the aspergilloma.  Clin Radiol. 1966;  18 432-438
    PubMedGoogle Scholar
  • 93 Kathuria S K, Rippon J. Non-Aspergillus aspergilloma.  Am J Clin Pathol. 1982;  78 870-873
    PubMedGoogle Scholar
  • 94 McCarthy D S, Peppys J. Pulmonary aspergilloma: clinical immunology.  Clin Allergy. 1973;  3 57-70
    PubMedGoogle Scholar
  • 95 Wollschlager C, Kahn F. Aspergillomas complicating sarcoidosis: a prospective study of 100 patients.  Chest. 1984;  86 585-588
    CrossrefPubMedGoogle Scholar
  • 96 Torpoco J O, Yousuffuddin M, Pate J W. Aspergilloma within a malignant pulmonary cavity.  Chest. 1976;  69 561-563
    PubMedGoogle Scholar
  • 97 Makker H, McConnochie K, Gibbs A R. Postirradiation pulmonary fibrosis complicated by aspergilloma and bronchocentric granulomatosis.  Thorax. 1989;  44 676-677
    PubMedGoogle Scholar
  • 98 Solit R W, McKeown J J, Smullens S. The surgical implications of intracavitary mycetomas (fungus balls).  J Thorac Cardiovasc Surg. 1971;  62 411-422
    PubMedGoogle Scholar
  • 99 Joynson D HM. Pulmonary aspergilloma.  Br J Clin Pract. 1977;  31 207-216
    PubMedGoogle Scholar
  • 100 Schwartz J, Baum G L, Straub M. Cavitary histoplasmosis complicated by fungus ball.  Am J Med. 1961;  31 692-700
    CrossrefPubMedGoogle Scholar
  • 101 Sarosi G A, Silberfarb P M, Saliba N A et al.. Aspergillomas occurring in blastomycotic cavities.  Am Rev Respir Dis. 1971;  104 581-584
    PubMedGoogle Scholar
  • 102 Haslock I. Ankylosing spondylitis.  Baillieres Clin Rheumatol. 1993;  7 99-115
    PubMedGoogle Scholar
  • 103 Bruce R A. A case of pulmonary aspergillosis.  Tubercle. 1957;  38 203-205
    PubMedGoogle Scholar
  • 104 Flye M W, Sealy W C. Pulmonary aspergilloma: a report of its occurrence in two patients with cyanotic heart disease.  Ann Thorac Surg. 1975;  20 196-203
    PubMedGoogle Scholar
  • 105 Aslam P A, Eastridge C E, Hughes F A. Aspergillosis of the lung: an 18-year experience.  Chest. 1971;  59 28-32
    PubMedGoogle Scholar
  • 106 Addrizzo-Harris D J, Harkin T J, McGuinness G et al.. Pulmonary aspergilloma and AIDS.  Chest. 1997;  111 612-618
    CrossrefPubMedGoogle Scholar
  • 107 Shah A, Khan Z U, Chaturvedi S, Malik G B, Randhawa H S. Concomitant allergic Aspergillus sinusitis and allergic bronchopulmonary aspergillosis associated with familial occurrence allergic bronchopulmonary aspergillosis.  Ann Allergy. 1990;  64 507-512
    PubMedGoogle Scholar
  • 108 Pimentel J C. Pulmonary calcification in the tumor-like form of pulmonary aspergillosis: pulmonary aspergilloma.  Am Rev Respir Dis. 1966;  94 208-216
    PubMedGoogle Scholar
  • 109 Campbell M J, Clayton Y M. Bronchopulmonary aspergillosis: a correlation of clinical and laboratory findings in 272 patients investigated for bronchopulmonary aspergillosis.  Am Rev Respir Dis. 1964;  89 186-196
    PubMedGoogle Scholar
  • 110 Hilvering C, Stevens E AM, Orie N GM. Fever in aspergillus mycetoma.  Thorax. 1970;  25 19-24
    PubMedGoogle Scholar
  • 111 Binder R E, Faling L J, Putatch R D et al.. Chronic necrotizing pulmonary aspergillosis: a discrete clinical entity.  Medicine. 1982;  60 109-124
    PubMedGoogle Scholar
  • 112 Faulkner S L, Vernon R, Brown P P et al.. Hemoptysis and pulmonary aspergilloma: operative versus nonoperative treatment.  Ann Thorac Surg. 1978;  25 389-392
    PubMedGoogle Scholar
  • 113 Lewis M M, Mortelliti M P, Yeager Jr H, Tsou E. Clinical bronchiectasis complicating pulmonary sarcoidosis: a case series of seven patients.  Sarcoidosis Vasc Diffuse Lung Dis. 2002;  19 154-159
    PubMedGoogle Scholar
  • 114 Tomlinson J, Sahn S A. Aspergilloma in sarcoidosis and tuberculosis.  Chest. 1987;  92 505-508
    CrossrefPubMedGoogle Scholar
  • 115 Tomee J, VanDer Werf T, Latge J et al.. Serologic monitoring of disease and treatment in a patient with pulmonary aspergilloma.  Am J Respir Crit Care Med. 1995;  151 199-204
    PubMedGoogle Scholar
  • 116 Kauffman C. Quandary about treatment of aspergillomas persists.  Thorax. 1996;  347 1640
    PubMedGoogle Scholar
  • 117 Daly R C, Pairolero P C, Piehler J M et al.. Pulmonary aspergilloma: results of treatment.  J Thorac Cardiovasc Surg. 1986;  92 981-988
    PubMedGoogle Scholar
  • 118 Soltanzadeh H, Wychulis A R, Sadr F et al.. Surgical treatment of aspergilloma.  Ann Surg. 1977;  186 13-16
    PubMedGoogle Scholar
  • 119 Jewkes J, Kay P H, Paneth M et al.. Pulmonary aspergilloma: analysis of prognosis in relation to hemoptysis and survey of treatment.  Thorax. 1983;  38 572-578
    CrossrefPubMedGoogle Scholar
  • 120 Garvey J, Crastnopol P, Weisz D et al.. The surgical treatment of pulmonary aspergillomas.  J Thorac Cardiovasc Surg. 1977;  74 642-647
    PubMedGoogle Scholar
  • 121 Israel H L, Lenchner G S, Atkinson G W. Sarcoidosis and aspergilloma: the role of surgery.  Chest. 1982;  82 430-432
    CrossrefPubMedGoogle Scholar
  • 122 Kaestel M, Meyer W, Mittelmeier H O et al.. Pulmonary aspergilloma: clinical findings and surgical treatment.  Thorac Cardiovasc Surg. 1999;  47 340-345
    PubMedGoogle Scholar
  • 123 Massard G, Roeslin N, Wihlm J M et al.. Pleuropulmonary aspergilloma: clinical spectrum and results of surgical treatment.  Ann Thorac Surg. 1992;  54 1159-1164
    PubMedGoogle Scholar
  • 124 Conlan A A, Abramor E, Moyes D G. Pulmonary aspergilloma: indications for surgical intervention: an analysis of 22 cases.  S Afr Med J. 1987;  71 285-288
    PubMedGoogle Scholar
  • 125 Battaglini J W, Murray G F, Kaegy B A et al.. Surgical management of symptomatic pulmonary aspergilloma.  Ann Thorac Surg. 1985;  39 512-516
    PubMedGoogle Scholar
  • 126 Kay P H. Surgical management of pulmonary aspergilloma [editorial].  Thorax. 1997;  52 753-754
    PubMedGoogle Scholar
  • 127 Chen J C, Chang Y L, Luh S P et al.. Surgical treatment for pulmonary aspergilloma: a 28-year experience.  Thorax. 1997;  52 810-813
    PubMedGoogle Scholar
  • 128 Chatzimichalis A, Massard G, Kessler R et al.. Bronchopulmonary aspergilloma: a reappraisal.  Ann Thorac Surg. 1998;  65 927-929
    CrossrefPubMedGoogle Scholar
  • 129 Oakley R E, Petrou M, Goldstraw P. Indications and outcome of surgery for pulmonary aspergilloma.  Thorax. 1997;  52 813-815
    PubMedGoogle Scholar
  • 130 Giron J M, Poey C G, Fajadet P P et al.. Inoperable pulmonary aspergilloma: percutaneous CT-guided injection with glycerin and amphotericin B paste in 15 cases.  Radiology. 1993;  188 825-827
    PubMedGoogle Scholar
  • 131 Jackson M, Flower C DR, Shneerson J M. Treatment of symptomatic pulmonary aspergillomas with intracavitary instillation of amphotericin B through an indwelling catheter.  Thorax. 1993;  48 928-930
    PubMedGoogle Scholar
  • 132 Munk P L, Vellet A D, Rankin R N et al.. Intracavitary aspergilloma: transthoracic percutaneous injection of amphotericin B solution.  Radiology. 1993;  188 821-823
    PubMedGoogle Scholar
  • 133 Lee K S, Kim H T, Kim Y H et al.. Treatment of hemoptysis in patients with cavitary aspergilloma of the lung: value of percutaneous instillation of amphotericin B.  AJR Am J Roentgenol. 1993;  161 727-731
    PubMedGoogle Scholar
  • 134 Klein J S, Fang K, Chang M C. Percutaneous transcatheter treatment of an intracavitary aspergilloma.  Cardiovasc Intervent Radiol. 1993;  16 321-324
    PubMedGoogle Scholar
  • 135 Yamada H, Kohno S, Koga H et al.. Topical treatment of pulmonary aspergilloma by antifungals.  Chest. 1993;  103 1421-1425
    PubMedGoogle Scholar
  • 136 Hargis J L, Bone R C, Stewart J et al.. Intracavitary amphotericin B in the treatment of symptomatic pulmonary aspergillomas.  Am J Med. 1980;  68 389-394
    CrossrefPubMedGoogle Scholar
  • 137 Rumbak M, Kohler G, Eastrige C et al.. Topical treatment of life-threatening hemoptysis from aspergillomas.  Thorax. 1996;  51 253-255
    PubMedGoogle Scholar
  • 138 Guleria R, Gupta D, Jindal S K. Treatment of pulmonary aspergilloma by endoscopic intracavitary instillation of ketoconazole.  Chest. 1993;  103 1301-1302
    PubMedGoogle Scholar
  • 139 Kaplan J, Johns C J. Mycetomas in pulmonary sarcoidosis: nonsurgical management.  J Hopkins Med J. 1979;  145 157-161
    PubMedGoogle Scholar
  • 140 Remy J, Arnaud A, Fardou H et al.. Treatment of hemoptysis by embolization of bronchial arteries.  Radiology. 1977;  122 33-37
    CrossrefPubMedGoogle Scholar
  • 141 Uflacker R, Kaemmerer A, Neves C et al.. Management of massive hemoptysis by bronchial artery embolization.  Radiology. 1983;  146 627-634
    CrossrefPubMedGoogle Scholar
  • 142 Falkson C, Sur R, Pacella J. External beam radiotherapy: a treatment option for massive hemoptysis caused by mycetoma.  Clin Oncol. 2002;  14 233-235
    CrossrefPubMedGoogle Scholar
  • 143 Shneerson J M, Emerson P A, Phillips R H. Radiotherapy for massive hemoptysis from an aspergilloma.  Thorax. 1980;  35 953-954
    PubMedGoogle Scholar
  • 144 Mikami M, Nakamura S, Kawakami M. Pulmonary aspergilloma successfully treated with long-term intermittent inhalation therapy with miconazole.  Intern Med. 1993;  32 247-250
    PubMedGoogle Scholar
  • 145 Hammerman K H, Sarosi G A, Tosh F E. Amphotericin B in the treatment of saprophytic forms of pulmonary aspergillosis.  Am Rev Respir Dis. 1974;  109 57-62
    PubMedGoogle Scholar
  • 146 Van Cutsem J, Van Gerven F, Vam De Ven M A et al.. Itraconazole, a new triazole that is orally active in aspergillosis.  Antimicrob Agents Chemother. 1984;  26 615-619
    PubMedGoogle Scholar
  • 147 Jennings T S, Hardin T C. Treatment of aspergillosis with itraconazole.  Ann Pharmacother. 1993;  27 1206-1211
    PubMedGoogle Scholar
  • 148 Campbell J H, Winter J H, Richardson M D et al.. Treatment of pulmonary aspergilloma with itraconazole.  Thorax. 1991;  46 839-841
    PubMedGoogle Scholar
  • 149 Dupont B. Itraconazole therapy in aspergillosis: study in 49 patients.  J Am Acad Dermatol. 1990;  23 607-614
    CrossrefPubMedGoogle Scholar
  • 150 Impens N, De Greve J, DeBeule K et al.. Oral treatment with itraconazole of aspergilloma in cavitary lung cancer.  Eur Respir J. 1990;  3 837-839
    PubMedGoogle Scholar
  • 151 Tsubura E. Multicenter clinical trial of itraconazole in the treatment of pulmonary aspergilloma.  Kekkaku. 1997;  72 557-564
    PubMedGoogle Scholar
  • 152 Judson M A. Diagnosis and management of aspergilloma.  Pulmonary Critical Care Update. 2002;  15 1-14
    PubMedGoogle Scholar

Marc A JudsonM.D. 

Division of Pulmonary and Critical Care Medicine, Medical University of South Carolina

96 Jonathan Lucas St.

Charleston, SC 29425

Email: judsonma@MUSC.edu

      >